-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Agios Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
- Agios Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$96.1M, a 14.7% decline year-over-year.
- Agios Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$365M, a 73.7% decline year-over-year.
- Agios Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$352M, a 51.9% decline from 2022.
- Agios Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$232M, a 114% decline from 2021.
- Agios Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $1.6B.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)